Abrahão Renata, Lichtensztajn Daphne Y, Ribeiro Raul C, Marina Neyssa M, Keogh Ruth H, Marcos-Gragera Rafael, Glaser Sally L, Keegan Theresa H M
Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Cancer Prevention Institute of California, Fremont, California.
Pediatr Blood Cancer. 2015 Oct;62(10):1819-25. doi: 10.1002/pbc.25544. Epub 2015 Apr 20.
Despite advances in treatment, survival from acute lymphoblastic leukemia (ALL) remains lower among non-White children than White children in the US. We investigated the association of race/ethnicity and socioeconomic status (SES) with survival.
We analyzed 9,295 Californian children (3,251 Whites, 4,890 Hispanics, 796 Asians, and 358 Blacks) aged ≤ 19 years diagnosed with a first primary ALL during 1988-2011. We used the Kaplan-Meier method to estimate survival at 1, 5, and 10 years after diagnosis for three calendar periods. Hazard ratios of death for race/ethnicity, SES, and clinical factors were estimated by Cox regression models.
Median follow-up time was 7.4 years (range 0-25 years). Over time, survival after ALL improved steadily, but inequalities persisted across races/ethnicities. Five-year survival (95% confidence interval) was 85.0% (83.6-86.2) for White, 81.4% (78.3-84.0) for Asian, 79.0% (77.8-80.2) for Hispanic, and 74.4% (69.4-78.8) for Black children. In multivariable-adjusted models, the hazard of death was increased by 57% among Black, 38% among Hispanic, and 33% among Asian children compared with White children. Patients residing in the lowest SES neighborhoods at diagnosis had a 39% increased risk of death relative to those living in higher SES neighborhoods.
Despite significant improvements in survival, non-White children and children residing in low SES neighborhoods experienced worse survival even after adjusting for potential confounders. Our findings highlight the need to capture specific information on disease biology, treatment, and treatment adherence to better understand the predictors of lower survival in minority and low SES groups.
尽管治疗取得了进展,但在美国,非白人儿童急性淋巴细胞白血病(ALL)的生存率仍低于白人儿童。我们调查了种族/族裔和社会经济地位(SES)与生存率之间的关联。
我们分析了1988年至2011年期间诊断为首次原发性ALL的9295名加利福尼亚州19岁及以下儿童(3251名白人、4890名西班牙裔、796名亚裔和358名黑人)。我们使用Kaplan-Meier方法估计三个日历期诊断后1年、5年和10年的生存率。通过Cox回归模型估计种族/族裔、SES和临床因素的死亡风险比。
中位随访时间为7.4年(范围0至25年)。随着时间的推移,ALL后的生存率稳步提高,但不同种族/族裔之间的不平等仍然存在。白人儿童的五年生存率(95%置信区间)为85.0%(83.6 - 86.2),亚裔为81.4%(78.3 - 84.0),西班牙裔为79.0%(77.8 - 80.2),黑人儿童为74.4%(69.4 - 78.8)。在多变量调整模型中,与白人儿童相比,黑人儿童的死亡风险增加了57%,西班牙裔儿童增加了38%,亚裔儿童增加了33%。诊断时居住在SES最低社区的患者相对于居住在SES较高社区的患者死亡风险增加了39%。
尽管生存率有显著提高,但即使在调整潜在混杂因素后,非白人儿童和居住在低SES社区的儿童生存率仍较差。我们的研究结果强调需要获取有关疾病生物学特征、治疗和治疗依从性的具体信息,以更好地了解少数族裔和低SES群体生存率较低的预测因素。